Landmark trials of medicine, told in a single sentence.
35 pulmonology trials in 11 topics.
Topics in pulmonology
COPD
Inhaled therapy, triple inhalers, ICS withdrawal, exacerbation management and β-blocker safety in obstructive lung disease.Asthma
ICS-formoterol PRN, LABA safety, single-inhaler triple therapy and biologics for severe asthma.Interstitial lung disease & IPF
Antifibrotics in IPF, progressive fibrosing ILD and SSc-ILD; refutation of immunosuppression for IPF.Lung cancer screening
Low-dose CT screening trials that defined modern lung-cancer screening programmes.Pleural disease
Intrapleural fibrinolytics for empyema and indwelling catheters for malignant effusion.Sleep-disordered breathing
CPAP for obstructive sleep apnoea and its (lack of) effect on cardiovascular events.Smoking cessation
Pharmacotherapy comparisons for tobacco dependence.Pneumonia
Corticosteroids and adjuncts in severe community-acquired pneumonia.Cystic fibrosis
CFTR modulators that transformed survival in cystic fibrosis.Bronchiectasis
DPP-1 inhibition and exacerbation prevention in non-CF bronchiectasis.α-1-antitrypsin deficiency
Intravenous augmentation therapy for severe AATD-related emphysema.
In 17,187 patients with suspected acute myocardial infarction, aspirin plus intravenous streptokinase reduced 5-week vascular mortality compared with placebo.